Filing Details

Accession Number:
0001140361-15-034405
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-03 18:21:20
Reporting Period:
2015-09-02
Filing Date:
2015-09-03
Accepted Time:
2015-09-03 18:21:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266163 M Kristine Ball C/O Relypsa, Inc.
100 Cardinal Way
Redwood City CA 94063
Chief Financial Officer & Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-02 646 $22.96 15,040 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. Shares sold were acquired pursuant to the Issuer's Employee Stock Purchase Plan on August 31, 2015.
  3. Includes 13,875 restricted stock units.